Cargando…
Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice
Platelet-derived growth factor (PDGF) has been implicated in the pathogenesis of pulmonary fibrosis. Nintedanib, a multi-kinase inhibitor that targets several tyrosine kinases, including PDGF receptor (PDGFR), was recently approved as an anti-fibrotic agent to reduce the deterioration of FVC in pati...
Autores principales: | Kishi, Masami, Aono, Yoshinori, Sato, Seidai, Koyama, Kazuya, Azuma, Momoyo, Abe, Shuichi, Kawano, Hiroshi, Kishi, Jun, Toyoda, Yuko, Okazaki, Hiroyasu, Ogawa, Hirohisa, Uehara, Hisanori, Nishioka, Yasuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312310/ https://www.ncbi.nlm.nih.gov/pubmed/30596712 http://dx.doi.org/10.1371/journal.pone.0209786 |
Ejemplares similares
-
Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
por: Sato, Seidai, et al.
Publicado: (2017) -
IMD-4690, a Novel Specific Inhibitor for Plasminogen Activator Inhibitor-1, Reduces Allergic Airway Remodeling in a Mouse Model of Chronic Asthma via Regulating Angiogenesis and Remodeling-Related Mediators
por: Tezuka, Toshifumi, et al.
Publicado: (2015) -
The lymphocyte-specific protein tyrosine kinase-specific inhibitor A-770041 attenuates lung fibrosis via the suppression of TGF-β production in regulatory T-cells
por: Kagawa, Kozo, et al.
Publicado: (2022) -
Development of improved method to identify and analyze lung fibrocytes with flow cytometry in a reporter mouse strain
por: Kawano, Hiroshi, et al.
Publicado: (2020) -
A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis
por: Imakura, Takeshi, et al.
Publicado: (2023)